Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Atezolizumab + Trastuzumab + Vinorelbine
Sponsor: SOLTI Breast Cancer Research Group
Collaborators: Roche Pharma AG